RELMADA THERAPEUTICS, INC.
RLMD—
RELMADA THERAPEUTICS, INC.RLMD$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-1.45
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$13,070
Net income
$-57.39M
Net margin
-439060.2%
Gross margin
24.8%
Dividends & financials
RELMADA THERAPEUTICS, INC. (RLMD) reported revenue of $13,070 and net income of $-57.39M, or $-1.45 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.